Catalyst Wire Dossier Catalyst Wire Dossier

GSK3640254

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for GSK3640254, covering 2019-09-06 to 2024-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Relative Bioavailability and Food-Effect Study of the Fixed Dose Combination of GSK3640254 and Dolutegravir (DTG) in Healthy Participants [Phase 1]

See pricing